Media Advisory - Meeting of Federal, Provincial and Territorial Ministers Responsible for Seniors
GATINEAU, QC, April 25, 2023 /CNW/ - The Federal Minister of Seniors, Kamal Khera, along with Raymond Cho, Minister for Seniors and Accessibility Ontario, will deliver remarks as co-chairs of the Meeting of Federal, Provincial and Territorial Ministers Responsible for Seniors in Mississauga, Ontario.
A media availability will follow.
Please note that all details are subject to change. All times are local.
DATE:
Wednesday, April 26, 2023
TIME:
3:15 p.m. EDT
PLACE:
Hilton Toronto Airport Hotel & Suites,
5875 Airport Road,
Mississauga, Ontario
Journalists who want to participate must register by contacting [email protected] with their name and media outlet before 3:00 p.m. EDT on Wednesday, April 26, 2023. Please indicate if attendance will be in-person or virtual. Zoom link will be provided upon registration.
In-person attendance instructions:
Arrive between 20 and 30 minutes prior to the announcement.
Do not attend if you have any symptoms associated with COVID-19.
Virtual attendance instructions:
Log on 20 minutes prior to the announcement.
To help ensure optimal simultaneous interpretation sound quality, journalists are encouraged to use a microphone (headphones/headset) or, when possible, a landline, and to avoid using speaker mode if queuing up for questions.
GSK plc (LSE/NYSE: GSK) today announced positive results from an interim analysis of the DREAMM-8 phase III head-to-head trial evaluating belantamab mafodotin, in combination with pomalidomide plus dexamethasone (PomDex), versus a standard of care,...
ConcertAI, the leading oncology real-world evidence data and AI SaaS technology company, today announced a collaboration with NVIDIA to advance a broad set of translational and clinical development solutions within the ConcertAI CARA AI platform....
ASRock Rack Inc., a leading innovative server company, has launched several scale-up servers leveraging the NVIDIA Blackwell architecture at the ASRock Rack booth L0818 in Hall 1 of COMPUTEX 2024. The highlights of the launch are the ORV3 NVIDIA...
Puma Biotechnology, Inc. , a biopharmaceutical company, announced the presentation of biomarker findings from a Phase II randomized clinical trial of alisertib alone vs. alisertib + fulvestrant for the treatment of patients with endocrine and CDK4/6...
Flamingo Therapeutics ("Flamingo") today announced the presentation of a Trial-in-Progress poster at the 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO 2024) taking place in Chicago,...